Abstract
Monitoring COVID-19 patients with COPD has become one of the major tasks in preventing transmission and delivering emergency healthcare services after vaccination in case of any issues. Most COVID-19-affected patients are suggested to self-quarantine at home or in institutionalized quarantine centers. In such cases, it is essential to provide remote healthcare services. For remote healthcare monitoring, two approaches are being considered in this study, which include mHealth and Telehealth. A mixed-methods approach is adopted, where survey questionnaires are used for collecting information from 108 patients and semi-structured interviews are used with seven physicians regarding mHealth and Telehealth approaches. Survey results indicated that mHealth is rated to be slightly more effective than Telehealth, and interview results indicated that Telehealth is identified to be slightly more effective than mHealth in relation to parameters including usefulness, ease of use and learnability, interface and interaction quality, reliability, and satisfaction. However, both physicians and patients opined that both mHealth and Telehealth have a promising future with increasing adoption. Based on the findings, it can be concluded that both mHealth and Telehealth are considered to be effective in delivering remote care for COPD patients infected with COVID-19 at home. Implications of the study findings are discussed.
Highlights
Irene Torres-SanchezCOVID-19, since its identification in December 2019, has been affecting many people across the world, resulting in different waves of rising infections and deaths
Given the severity associated with COVID-19-infected chronic obstructive pulmonary disease (COPD) patients, there is increasing pressure on the health system to provide additional care
This study has compared and evaluated mHealth approaches in remote monitoring of COPD patients diagnosed with COVID-19
Summary
COVID-19, since its identification in December 2019, has been affecting many people across the world, resulting in different waves of rising infections and deaths. As of COVID-19 patients with COPD have a high risk of admission to an intensive care unit, mechanical ventilation, or death [10]. 2 (ACE2), the reported host receptor of the virus responsible for COVID-19 (SARS-CoV2), have been observed to be increased in patients with COPD [11]. Given the severity associated with COVID-19-infected COPD patients, there is increasing pressure on the health system to provide additional care. There is a need to maintain and reinforce followup and close management for these patients, with the aim of limiting collateral effects that. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
